Literature DB >> 12726858

Protein microarrays: meeting analytical challenges for clinical applications.

Lance A Liotta1, Virginia Espina, Arpita I Mehta, Valerie Calvert, Kevin Rosenblatt, David Geho, Peter J Munson, Lynn Young, Julia Wulfkuhle, Emanuel F Petricoin.   

Abstract

Protein microarrays, one emerging class of proteomic technologies, have broad applications for discovery and quantitative analysis. A rapidly expanding use of this technology is the acquisition of information about the posttranslational modifications of proteins reflecting the activity state of signal pathways and networks, and is now employed for the analysis of biopsy samples in clinical trial research.

Mesh：

Substances：

Year:  2003        PMID： 12726858     DOI： 10.1016/s1535-6108(03)00086-2

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  95 in total

1.  Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray.

Authors:  Martin J Romeo; John Wunderlich; Lien Ngo; Steven A Rosenberg; Seth M Steinberg; David M Berman
Journal:  Clin Cancer Res       Date:  2006-04-15       Impact factor: 12.531

2.  [Update on protein analysis of fixed tissues].

Authors:  K-F Becker; D Berg; K Malinowsky; C Wolff; B Ergin; S Meding; A Walch; H Höfler
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

3.  [Analysis of signalling pathways in formalin-fixed breast cancer tissues].

Authors:  D Berg; H Bronger; A Walch; H Höfler; K-F Becker
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 4.  Cell signaling regulation by protein phosphorylation: a multivariate, heterogeneous, and context-dependent process.

Authors:  Evan K Day; Nisha G Sosale; Matthew J Lazzara
Journal:  Curr Opin Biotechnol       Date:  2016-07-06       Impact factor: 9.740

5.  Quantification of kinase activity in cell lysates via photopatterned macroporous poly(ethylene glycol) hydrogel arrays in microfluidic channels.

Authors:  Andrew G Lee; David J Beebe; Sean P Palecek
Journal:  Biomed Microdevices       Date:  2012-04       Impact factor: 2.838

Review 6.  Genomics and proteomics: role in the management of multiple sclerosis.

Authors:  Ludwig Kappos; Lutz Achtnichts; Frank Dahlke; Jens Kuhle; Y Naegelin; Rupert Sandbrink; Raija L P Lindberg
Journal:  J Neurol       Date:  2005-09       Impact factor: 4.849

Review 7.  Molecular screening of cancer: the future is here.

Authors:  Sudhir Srivastava
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

8.  Application of physicochemically modified silicon substrates as reverse-phase protein microarrays.

Authors:  A Jasper Nijdam; Michael R Zianni; Edward E Herderick; Mark M-C Cheng; Jenifer R Prosperi; Fredika A Robertson; Emanuel F Petricoin; Lance A Liotta; Mauro Ferrari
Journal:  J Proteome Res       Date:  2009-03       Impact factor: 4.466

9.  Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.

Authors:  Rehan Akbani; Karl-Friedrich Becker; Neil Carragher; Ted Goldstein; Leanne de Koning; Ulrike Korf; Lance Liotta; Gordon B Mills; Satoshi S Nishizuka; Michael Pawlak; Emanuel F Petricoin; Harvey B Pollard; Bryan Serrels; Jingchun Zhu
Journal:  Mol Cell Proteomics       Date:  2014-04-28       Impact factor: 5.911

10.  Elevated TNFR1 and serotonin in bone metastasis are correlated with poor survival following bone metastasis diagnosis for both carcinoma and sarcoma primary tumors.

Authors:  Antonella Chiechi; Chiara Novello; Giovanna Magagnoli; Emanuel F Petricoin; Jianghong Deng; Maria S Benassi; Piero Picci; Iosif Vaisman; Virginia Espina; Lance A Liotta
Journal:  Clin Cancer Res       Date:  2013-03-14       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.